Autism and Private Equity: A Cautionary Tale
What does the bankruptcy of CARD, the largest autism treatment company in the U.S., have to teach us about the role of private equity in health care?
Does Applied Behavior Analysis Really Help People with Autism?
The leading U.S. therapy for autism is no panacea and has shown mixed results. Critics say it’s time to look for alternatives—and consult people with autism.
The Urgent Problem of Regulating AI in Medicine
How should medical AI be regulated, and who is responsible when deadly mistakes occur?
The Rise of “Wet” Artificial Intelligence
Combining AI with traditional wet lab work creates a virtuous circle from lab to data and back to the lab.
Renee Wegrzyn Plans to Level Up U.S. Health with ARPA-H
As head of the government’s new federal agency, she’s attacking a wide range of problems from the molecular to the societal.
What Does Venture Capital Have Against Femtech?
Tech companies building products that focus on women’s health still struggle to attract VC funding.
Building a Better Microbiome
Stephanie Culler is using genetically engineered, synthetic probiotics to overhaul treatments for a host of ailments.
Can We Learn to Embrace Robotic Caregivers?
An aging population and elder care shortages means we may not have a choice.
No Spike, No Crash
A new functional sparkling water from the founders of Fiji Water and Oatly claims to manage metabolic health by helping avoid blood sugar spikes after meals.